We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Bayer Aktiengesellschaft (PK) | USOTC:BAYRY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 7.60 | 7.59 | 7.68 | 7.69 | 7.59 | 7.66 | 2,551,609 | 21:30:14 |
From May 2019 to May 2024
By Dieter Holger
Bayer AG (BAYN.XE) said Thursday that it will donate 50 million units of hemophilia A treatments this year to support people suffering from the blood-clotting disorder in countries with poor healthcare.
The German pharmaceutical giant made the pledge as part of a new five-year partnership with the World Federation of Hemophilia Humanitarian Aid Program. The partnership will treat up to 5,000 people in more than 60 countries.
Hemophilia, which is a largely inherited bleeding disorder, affects around 400,000 people globally, with hemophilia A the most common variant. Some 75% of people with bleeding disorders live in developing countries without access to adequate treatment, according to the WFH.
Write to Dieter Holger at dieter.holger@dowjones.com; @dieterholger
(END) Dow Jones Newswires
May 23, 2019 07:17 ET (11:17 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Bayer Aktiengesellschaft (PK) Chart |
1 Month Bayer Aktiengesellschaft (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
